Ftse Mib
34.603,61
-0,64%
DAX
18.726,76
-0,21%
S&P 500
5.321,41
0,25%
NASDAQ
16.832,62
0,22%
Bitcoin
69.941,06
-0,27%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Europa EU MDxHealth SA (MDXH) MDxHealth SA (MDXH) Notizie

MDXH

MDxHealth (MDXH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:EU:MDXH
DataOraFonteTitoloSimboloCompagnia
16/02/202414:45GlobeNewswire Inc.Mdxhealth Announces Resignation of Board MemberEU:MDXHMDxHealth SA
08/01/202422:00GlobeNewswire Inc.MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue GuidanceEU:MDXHMDxHealth SA
18/12/202307:00GlobeNewswire Inc.MDxHealth Announces Completion of Transition to Single Listing on NasdaqEU:MDXHMDxHealth SA
27/11/202307:00GlobeNewswire Inc.MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on NasdaqEU:MDXHMDxHealth SA
14/11/202322:00GlobeNewswire Inc.MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare ConferenceEU:MDXHMDxHealth SA
13/11/202322:00GlobeNewswire Inc.MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding Shares and Voting RightsEU:MDXHMDxHealth SA
13/11/202322:00GlobeNewswire Inc.MDxHealth annonce la réalisation de son regroupement d'actions, et la mise à jour des actions et des droits de vote en circulationEU:MDXHMDxHealth SA
08/11/202322:00GlobeNewswire Inc.MDxHealth communique ses résultats pour le troisième trimestre et la période de neuf mois clôturée le 30 septembre 2023EU:MDXHMDxHealth SA
08/11/202322:00GlobeNewswire Inc.MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023EU:MDXHMDxHealth SA
06/11/202307:00GlobeNewswire Inc.MDxHealth annonce l'approbation par ses actionnaires de la proposition de transition vers une cotation unique des actions sur le Nasdaq, ainsi que les détails du regroupement d'actionsEU:MDXHMDxHealth SA
06/11/202307:00GlobeNewswire Inc.MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share ConsolidationEU:MDXHMDxHealth SA
25/10/202322:00GlobeNewswire Inc.MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8EU:MDXHMDxHealth SA
20/10/202322:00GlobeNewswire Inc.Mdxhealth's New Share Capital Amount and New Number of SharesEU:MDXHMDxHealth SA
20/10/202322:00GlobeNewswire Inc.Nouveau montant du capital et nouveau nombre d'actions de MdxhealthEU:MDXHMDxHealth SA
09/10/202322:00GlobeNewswire Inc.MDxHealth Reports Preliminary Q3-2023 RevenuesEU:MDXHMDxHealth SA
09/10/202322:00GlobeNewswire Inc.MDxHealth communique ses revenus préliminaires pour le troisième trimestre de 2023EU:MDXHMDxHealth SA
02/10/202322:04GlobeNewswire Inc.MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders MeetingEU:MDXHMDxHealth SA
02/10/202322:04GlobeNewswire Inc.MDxHealth annonce une proposition de transition vers une cotation unique de ses actions sur le Nasdaq et convoque une assemblée générale extraordinaire des actionnairesEU:MDXHMDxHealth SA
26/09/202322:46GlobeNewswire Inc.Mdxhealth signe une collaboration de recherche avec l'Université d'Oxford pour évaluer la corrélation entre le test GPS et la progression du cancer de la prostate après un traitement pour un cancer de la prostate localiséEU:MDXHMDxHealth SA
26/09/202322:46GlobeNewswire Inc.Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate CancerEU:MDXHMDxHealth SA
23/08/202322:00GlobeNewswire Inc.MDxHealth communique ses résultats financiers T2 et S1 2023EU:MDXHMDxHealth SA
23/08/202322:00GlobeNewswire Inc.MDxHealth Reports Q2 and Half Year 2023 ResultsEU:MDXHMDxHealth SA
10/08/202322:00GlobeNewswire Inc.MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23EU:MDXHMDxHealth SA
09/08/202322:00GlobeNewswire Inc.Cigna Expands Commercial and Medicare Advantage Coverage to Include Mdxhealth’s Select mdx for Prostate Cancer TestEU:MDXHMDxHealth SA
30/06/202322:00GlobeNewswire Inc.MDxHealth Announces Results of its Extraordinary General Shareholders’ MeetingEU:MDXHMDxHealth SA
30/06/202322:00GlobeNewswire Inc.MDxHealth annonce les résultats de son assemblée générale extraordinaire des actionnairesEU:MDXHMDxHealth SA
05/06/202323:30GlobeNewswire Inc.MDxHealth Announces its Extraordinary General Shareholders’ MeetingEU:MDXHMDxHealth SA
05/06/202323:30GlobeNewswire Inc.MDxHealth annonce son assemblée générale extraordinaire des actionnairesEU:MDXHMDxHealth SA
25/05/202322:30GlobeNewswire Inc.MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ MeetingsEU:MDXHMDxHealth SA
25/05/202322:30GlobeNewswire Inc.MDxHealth annonce les résultats de ses assemblées générales ordinaire et extraordinaire des actionnairesEU:MDXHMDxHealth SA
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:EU:MDXH

La tua Cronologia

LSE
ASI
Asia Capital
BIT
UIJ531
Unicredit Bank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network